Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Staudt

Showing results (351-360 of 434) with videos related to

Pageof 44
Sort By:
Blood Advances|October 9, 2021
Frequent mutations of FBXO11 highlight BCL6 as a therapeutic target in Burkitt lymphomaChiara Pighi, Taek-Chin Cheong, Mara Compagno, et al.
International Journal of Cancer|June 12, 2013
Genome-wide methylation analyses identify a subset of mantle cell lymphoma with a high number of methylated CpGs and aggressive clinicopathological featuresAnna Enjuanes, Robert Albero, Guillem Clot, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 27, 2009
A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracyWilliam W L Choi, Dennis D Weisenburger, Timothy C Greiner, et al.
Cancer Discovery|May 4, 2023
Targeting N-linked Glycosylation for the Therapy of Aggressive LymphomasSebastian Scheich, Jiji Chen, Jiamin Liu, et al.
Blood|January 9, 2014
Determining cell-of-origin subtypes of diffuse large B-cell lymphoma using gene expression in formalin-fixed paraffin-embedded tissueDavid W Scott, George W Wright, P Mickey Williams, et al.
Leukemia|January 1, 2016
Recurrent activating mutations of CD28 in peripheral T-cell lymphomasJ Rohr, S Guo, J Huo, et al.
Cancer Cell|May 30, 2017
Inhibition of B Cell Receptor Signaling by Ibrutinib in Primary CNS LymphomaMichail S Lionakis, Kieron Dunleavy, Mark Roschewski, et al.
Cell|July 4, 2020
TBL1XR1 Mutations Drive Extranodal Lymphoma by Inducing a Pro-tumorigenic Memory FateLeandro Venturutti, Matt Teater, Andrew Zhai, et al.
Cancer Discovery|March 9, 2013
TYK2-STAT1-BCL2 pathway dependence in T-cell acute lymphoblastic leukemiaTakaomi Sanda, Jeffrey W Tyner, Alejandro Gutierrez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 7, 2017
A Phase 2/3 Multicenter, Randomized, Open-Label Study to Compare the Efficacy and Safety of Lenalidomide Versus Investigator's Choice in Patients with Relapsed or Refractory Diffuse Large B-Cell LymphomaMyron S Czuczman, Marek Trněný, Andrew Davies, et al.
Pageof 44

Showing results (351-360 of 434) with videos related to

Sort By:
Pageof 44
Blood Advances|October 9, 2021
Frequent mutations of FBXO11 highlight BCL6 as a therapeutic target in Burkitt lymphomaChiara Pighi, Taek-Chin Cheong, Mara Compagno, et al.
International Journal of Cancer|June 12, 2013
Genome-wide methylation analyses identify a subset of mantle cell lymphoma with a high number of methylated CpGs and aggressive clinicopathological featuresAnna Enjuanes, Robert Albero, Guillem Clot, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 27, 2009
A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracyWilliam W L Choi, Dennis D Weisenburger, Timothy C Greiner, et al.
Cancer Discovery|May 4, 2023
Targeting N-linked Glycosylation for the Therapy of Aggressive LymphomasSebastian Scheich, Jiji Chen, Jiamin Liu, et al.
Blood|January 9, 2014
Determining cell-of-origin subtypes of diffuse large B-cell lymphoma using gene expression in formalin-fixed paraffin-embedded tissueDavid W Scott, George W Wright, P Mickey Williams, et al.
Leukemia|January 1, 2016
Recurrent activating mutations of CD28 in peripheral T-cell lymphomasJ Rohr, S Guo, J Huo, et al.
Cancer Cell|May 30, 2017
Inhibition of B Cell Receptor Signaling by Ibrutinib in Primary CNS LymphomaMichail S Lionakis, Kieron Dunleavy, Mark Roschewski, et al.
Cell|July 4, 2020
TBL1XR1 Mutations Drive Extranodal Lymphoma by Inducing a Pro-tumorigenic Memory FateLeandro Venturutti, Matt Teater, Andrew Zhai, et al.
Cancer Discovery|March 9, 2013
TYK2-STAT1-BCL2 pathway dependence in T-cell acute lymphoblastic leukemiaTakaomi Sanda, Jeffrey W Tyner, Alejandro Gutierrez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 7, 2017
A Phase 2/3 Multicenter, Randomized, Open-Label Study to Compare the Efficacy and Safety of Lenalidomide Versus Investigator's Choice in Patients with Relapsed or Refractory Diffuse Large B-Cell LymphomaMyron S Czuczman, Marek Trněný, Andrew Davies, et al.
Pageof 44